FDA allows Houston cancer doctor to resume drug trial

Federal regulators have lifted a partial hold on a clinical trial performed by Stanislaw

World's First Gene Therapy Clinical Trial for Glycogen Storage Disease Approved by FDA - Connecticut Children's

Department of Labor and Food and Drug Administration Confirmations Hearing

MUSINGS OF A CANCER DOCTOR: War, Malaria, and the Nobel Prize, Article

Kentucky kidney transplant patient wants trial after getting cancer

A Triumph in the War Against Cancer, Science

Accelerated Approval for Anticancer Products

Elias Jabbour MD Anderson Cancer Center

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial - The Lancet Oncology

Harnessing the Immune System to Fight Cancer - The New York Times

Controversial Texas doctor Stanislaw Burzynski goes before disciplinary board